Dr. Ahmed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6550 Fannin St
Ste 1723
Houston, TX 77030Phone+1 713-441-1368
Summary
- Otolaryngology-Head and Neck Surgery
Rhinology-Anterior Skull Base Surgery Fellow at John's Hopkins University Hospital
Education & Training
- Johns Hopkins UniversityFellowship, Rhinology and Skull Base Surgery, 2019 - 2020
- Baylor College of MedicineResidency, Otolaryngology - Head and Neck Surgery, 2014 - 2019
- University of Chicago- Pritzker School of MedicineMD, 2009 - 2014
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2014
- University of Illinois at Urbana-ChampaignBS, Economics, Magna Cum Lade, 2005 - 2009
Certifications & Licensure
- TX State Medical License 2020 - 2026
- MD State Medical License 2019 - 2020
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Full Merit Academic Tuition Scholarship 2009-2014
Publications & Presentations
PubMed
- Histopathologic evaluation of Asian-American patients with chronic rhinosinusitis with nasal polyps.Arthur W Wu, Kevin Hur, Aria Jafari, Omar G Ahmed, Philip G Chen
International Forum of Allergy & Rhinology. 2024-11-01 - Chronic Rhinosinusitis and Mental Health.Najm S Khan, Meher Gajula, Lexi Goehring, Masayoshi Takashima, Aatin Dhanda
JAMA Otolaryngology-- Head & Neck Surgery. 2024-11-01 - Disparities in seeking care for olfactory and gustatory dysfunction: A population analysis.Daniel Gorelik, Aatin K Dhanda, Najm S Khan, Masayoshi Takashima, Tariq Nisar
International Forum of Allergy & Rhinology. 2024-10-01
Press Mentions
- Researchers Improve Success Rates for Chronic Rhinitis Treatments with Modified Surgical TechniqueOctober 8th, 2024
- Houston Methodist Researchers Lead First-of-Its-Kind Phase 2 Trial for HyposmiaAugust 22nd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: